Johannes Ruef

2.1k total citations
50 papers, 1.7k citations indexed

About

Johannes Ruef is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Hematology. According to data from OpenAlex, Johannes Ruef has authored 50 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cardiology and Cardiovascular Medicine, 19 papers in Surgery and 10 papers in Hematology. Recurrent topics in Johannes Ruef's work include Antiplatelet Therapy and Cardiovascular Diseases (11 papers), Coronary Interventions and Diagnostics (10 papers) and Acute Myocardial Infarction Research (10 papers). Johannes Ruef is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (11 papers), Coronary Interventions and Diagnostics (10 papers) and Acute Myocardial Infarction Research (10 papers). Johannes Ruef collaborates with scholars based in Germany, United States and Greece. Johannes Ruef's co-authors include Marschall S. Runge, Christoph Bode, Cam Patterson, Martin Moser, Karlheinz Peter, Gadiparthi N. Rao, Aruni Bhatnagar, Zhaoyong Hu, Carol A. Ballinger and Chris Horaist and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Johannes Ruef

49 papers receiving 1.7k citations

Peers

Countries citing papers authored by Johannes Ruef

Since Specialization

Citations

This map shows the geographic impact of Johannes Ruef's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johannes Ruef with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johannes Ruef more than expected).

Fields of papers citing papers by Johannes Ruef

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johannes Ruef. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johannes Ruef. The network helps show where Johannes Ruef may publish in the future.

Co-authorship network of co-authors of Johannes Ruef

This figure shows the co-authorship network connecting the top 25 collaborators of Johannes Ruef. A scholar is included among the top collaborators of Johannes Ruef based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johannes Ruef. Johannes Ruef is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Increased Restenosis Rates 12 Months After Coronary Implantation of the Sirolimus‐Eluting YUKON‐Choice Stent Compared to the Paclitaxel‐Eluting TAXUS Stent 2010 ·Clinical Cardiology ·Johannes Ruef, Hans Störger, Franz Schwarz, Jürgen Haase	11
2	The complement factor properdin induces formation of platelet-leukocyte aggregates via leukocyte activation 2008 ·Platelets ·Johannes Ruef, P. Kuehnl, Thomas Meinertz, Michael J. Merten	15
3	Closure of guide wire‐induced coronary artery perforation with a two‐component fibrin glue 2007 ·Catheterization and Cardiovascular Interventions ·Hans Störger, Johannes Ruef	27
4	Four-year results after brachytherapy for diffuse coronary in-stent restenosis: will coronary radiation therapy survive? 2007 ·Cardiovascular revascularization medicine ·Johannes Ruef, Manfred Hofmann, Hans Störger, Jürgen Haase	2
5	Coronary Stent Thrombosis Related to Aspirin Resistance: What are the Underlying Mechanisms? 2006 ·Journal of Interventional Cardiology ·Johannes Ruef, Roger Kranzhöfer	7
6	Initial Clinical Experience with the Protégé EverFlex™ Long Self‐Expanding Nitinol Stent in the Superficial Femoral Artery 2006 ·Journal of Interventional Cardiology ·Johannes Ruef, Manfred Hofmann, Jürgen Haase	5
7	Markers for endothelial dysfunction, but not markers for oxidative stress correlate with classical risk factors and the severity of coronary artery disease 2006 ·Scandinavian Cardiovascular Journal ·Johannes Ruef, Winfried März, Bernhard R. Winkelmann	18
8	Percutaneous Saphenous Vein Graft Interventions with and without Distal Filter Wire Protection 2005 ·Journal of Interventional Cardiology ·Manfred Hofmann, Hans Störger, Franz Schwarz, (unknown), (unknown), Johannes Ruef, Josef Schöpf, Jürgen Haase	5
9	Beeinflussen Statine die Effekte antithrombotischer Pharmaka? 2004 ·Medizinische Klinik ·Johannes Ruef	1
10	Abciximab, Eptifibatide, and Tirofiban Exhibit Dose-dependent Potencies to Dissolve Platelet Aggregates 2003 ·Journal of Cardiovascular Pharmacology ·Martin Moser, (unknown), Karlheinz Peter, Christoph Bode, Johannes Ruef	80
11	New antithrombotic drugs on the horizon 2003 ·Expert Opinion on Investigational Drugs ·Johannes Ruef, Hugo A. Katus	32
12	Gold-bound microtubules as a new ultrasound contrast agent 2002 ·Journal of the American College of Cardiology ·Helmut F. Kuecherer, Silke Behrens, Raffi Bekeredjian, Johannes Ruef, Eckhard Dinjus, (unknown), Eberhard Unger	1
13	Potential of gold-bound microtubules as a new ultrasound contrast agent 2002 ·Ultrasound in Medicine & Biology ·Raffi Bekeredjian, Silke Behrens, Johannes Ruef, Eckhard Dinjus, Eberhard Unger, (unknown), Helmut F. Kuecherer	18
14	Effects of Different Thrombolytic Treatment Regimen with Abciximab and Tirofiban on Platelet Aggregation and Platelet-Leukocyte Interactions: A Subgroup Analysis from the GUSTO V and FASTER Trials 2002 ·Journal of Thrombosis and Thrombolysis ·(unknown), Martin Moser, Karlheinz Peter, Helmut F. Kuecherer, Raffi Bekeredjian, Andreas Straub, Thomas K. Nordt, Christoph Bode, Johannes Ruef	11
15	Ecarin Clotting Time but not aPTT Correlates with PEG-Hirudin Plasma Activity 2001 ·Journal of Thrombosis and Thrombolysis ·Martin Moser, Johannes Ruef, Karlheinz Peter, Benedikt Köhler, Dietrich C. Gulba, (unknown), Thomas K. Nordt, (unknown), Christoph Bode	17
16	4-Hydroxynonenal induces apoptosis, NF-κB-activation and formation of 8-isoprostane in vascular smooth nmuscle cells 2001 ·Basic Research in Cardiology ·Johannes Ruef, Martin Moser, Christoph Bode, (unknown), Marschall S. Runge	77
17	Fluid shear stress as a regulator of gene expression in vascular cells: possible correlations with diabetic abnormalities 1999 ·Diabetes Research and Clinical Practice ·Maria Papadaki, Suzanne G. Eskin, Johannes Ruef, (unknown), L.V. McIntire	15
18	Stimulation of a Vascular Smooth Muscle Cell NAD(P)H Oxidase by Thrombin 1999 ·Journal of Biological Chemistry ·Cam Patterson, Johannes Ruef, Nageswara R. Madamanchi, Patricia A. Barry-Lane, Zhaoyong Hu, Chris Horaist, Carol A. Ballinger, Allan R. Brasier, Christoph Bode, Marschall S. Runge	278
19	THROMBIN ACTIVITY DURING AND AFTER THROMBOLYSIS WITH RETEPLASE OR ALTEPLASE IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION 1994 ·Circulation ·Christopher Bode, Benedikt Köhler, T. Nordt, Karlheinz Peter, Johannes Ruef, (unknown), (unknown)	3
20	A RECOMBINANT MOLECULE WITH HIGH-AFFINITY FOR FIBRIN EXHIBITS ANTITHROMBIN ACTIVITY AFTER CLEAVAGE BY FACTOR-XA 1994 ·Circulation ·Karlheinz Peter, Amitabh Gupta, Johannes Ruef, M S Runge, Christoph Bode	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact